Join the Donanemab group to help and get support from people like you.
Donanemab News
Anti-Amyloid Drug Shows Promise In Preventing Alzheimer's
MONDAY, March 24, 2025 – The best evidence yet that cutting-edge Alzheimer’s disease drugs might indeed ward off the degenerative brain disease has emerged from a small-scale study. An experimental d...
FDA Approves New Drug to Treat Alzheimer's, Kisunla
TUESDAY, July 2, 2024 – A new drug to treat Alzheimer's disease was approved by the U.S. Food and Drug Administration on Tuesday. In clinical trials, donanemab (Kisunla) modestly slowed the pace of...
FDA Approves Kisunla (donanemab-azbt) for the Treatment of Early Symptomatic Alzheimer's Disease
INDIANAPOLIS, July 2, 2024 /PRNewswire/ – The U.S. Food and Drug Administration (FDA) approved Kisunla™ (donanemab-azbt, 350 mg/20 mL once-monthly injection for IV infusion), Eli Lilly and Company's ...